Letter to the Editor: Reply to Topkan et al
Claudia Schweizer, Vratislav Strnad

TL;DR
The authors respond to feedback on their study about necrosis risk factors in interventional radiotherapy, acknowledging limitations and future research needs.
Contribution
The paper highlights the need for prospective data and unified reporting standards to better understand toxicity and recurrence in radiotherapy.
Findings
Retrospective data limits the evaluation of risk factors for necrosis in interventional radiotherapy.
Bone volume affected by radiation dose and catheter distance should be considered alongside mandible distance.
Disease-free survival estimates should ideally account for death events to improve comparability across studies.
Abstract
We thank the colleagues Topkan and the co-authors for their valuable comments on our study. As they stated correctly, there for sure are more factors influencing the development of necrosis – nicotine and alcohol might also play an important role, for example. Also some hints point at the distance of the catheters being associated with risk of necrosis. Due to the fact that the risk factors influence each other in their effect on the risk of necrosis and usually have an additive effect and due to the generally retrospective data collections in published articles on interventional radiotherapy in the oral cavity, some risk factors for late side effects cannot be perfectly recorded and evaluated. In our understanding, not only the distance to the mandible, but also the bone volume which is affected by radiation dose must be considered. No specific dose constraints exist for the mandible…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLymphoma Diagnosis and Treatment · Viral-associated cancers and disorders · Cancer Genomics and Diagnostics
Dear Editor,
We thank the colleagues Topkan and the co-authors for their valuable comments on our study. As they stated correctly, there for sure are more factors influencing the development of necrosis – nicotine and alcohol might also play an important role, for example. Also some hints point at the distance of the catheters being associated with risk of necrosis [1]. Due to the fact that the risk factors influence each other in their effect on the risk of necrosis and usually have an additive effect and due to the generally retrospective data collections in published articles on interventional radiotherapy in the oral cavity, some risk factors for late side effects cannot be perfectly recorded and evaluated. In our understanding, not only the distance to the mandible, but also the bone volume which is affected by radiation dose must be considered. No specific dose constraints exist for the mandible when applying interventional radiotherapy. We are currently analyzing further dose parameters available within CT-based planning workflows and hope for more detailed information on how we can improve the implants. Nevertheless, prospective data is needed to sufficiently address toxicity issues in a larger cohort of patients with long-term follow-up. As far as the disease-free survival is concerned, we indeed estimated this according to the current practice in several other published data without taking the event of death into account [2], [3]. This is obvious when looking at our results. Still, we agree that the different ways of presenting freedom of recurrence throughout the literature makes comparison rather difficult and should be unified. We thank you for your remark and will consider this in our future work.
Kind regards,
Claudia Schweizer
Vratislav Strnad
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Melzner W.J.Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: predictive factors for local control and late toxicity?Radiother Oncol 82220071671731725834010.1016/j.radonc.2006.12.004 · doi ↗ · pubmed ↗
- 2Petera J.High-dose-rate brachytherapy in early oral cancer with close or positive margins Brachytherapy 141201577832526403710.1016/j.brachy.2014.08.050 · doi ↗ · pubmed ↗
- 3Strnad V.Reirradiation for recurrent head and neck cancer with salvage interstitial pulsed-dose-rate brachytherapy: Long-term results Strahlenther Onkol 191620154955002557598110.1007/s 00066-014-0809-8 · doi ↗ · pubmed ↗
